Literature DB >> 29061651

TRPC5 Does Not Cause or Aggravate Glomerular Disease.

Xuexiang Wang1, Ranadheer R Dande1, Hao Yu1, Beata Samelko1, Rachel E Miller1, Mehmet M Altintas1, Jochen Reiser2.   

Abstract

Transient receptor potential channel 5 (TRPC5) is highly expressed in brain and kidney and mediates calcium influx and promotes cell migration. In the kidney, loss of TRPC5 function has been reported to benefit kidney filter dynamics by balancing podocyte cytoskeletal remodeling. However, in vivo gain-in-function studies of TRPC5 with respect to kidney function have not been reported. To address this gap, we developed two transgenic mouse models on the C57BL/6 background by overexpressing either wild-type TRPC5 or a TRPC5 ion-pore mutant. Compared with nontransgenic controls, neither transgenic model exhibited an increase in proteinuria at 8 months of age or a difference in LPS-induced albuminuria. Moreover, activation of TRPC5 by Englerin A did not stimulate proteinuria, and inhibition of TRPC5 by ML204 did not significantly lower the level of LPS-induced proteinuria in any group. Collectively, these data suggest that the overexpression or activation of the TRPC5 ion channel does not cause kidney barrier injury or aggravate such injury under pathologic conditions.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  TRPC5; calcium channels; glomerular disease; glomerular filtration barrier; podocyte; proteinuria

Mesh:

Substances:

Year:  2017        PMID: 29061651      PMCID: PMC5791075          DOI: 10.1681/ASN.2017060682

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Controlled expression of transgenes introduced by in vivo electroporation.

Authors:  Takahiko Matsuda; Constance L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-05       Impact factor: 11.205

3.  Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.

Authors:  Melissa Miller; Jie Shi; Yingmin Zhu; Maksym Kustov; Jin-bin Tian; Amy Stevens; Meng Wu; Jia Xu; Shunyou Long; Pu Yang; Alexander V Zholos; James M Salovich; C David Weaver; Corey R Hopkins; Craig W Lindsley; Owen McManus; Min Li; Michael X Zhu
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.

Authors:  Jochen Reiser; Krishna R Polu; Clemens C Möller; Peter Kenlan; Mehmet M Altintas; Changli Wei; Christian Faul; Stephanie Herbert; Ivan Villegas; Carmen Avila-Casado; Mary McGee; Hikaru Sugimoto; Dennis Brown; Raghu Kalluri; Peter Mundel; Paula L Smith; David E Clapham; Martin R Pollak
Journal:  Nat Genet       Date:  2005-05-27       Impact factor: 38.330

6.  TRPC6 enhances angiotensin II-induced albuminuria.

Authors:  Jason Eckel; Peter J Lavin; Elizabeth A Finch; Nirvan Mukerji; Jarrett Burch; Rasheed Gbadegesin; Guanghong Wu; Brandy Bowling; Alison Byrd; Gentzon Hall; Matthew Sparks; Zhu Shan Zhang; Alison Homstad; Laura Barisoni; Lutz Birbaumer; Paul Rosenberg; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2011-01-21       Impact factor: 10.121

Review 7.  Proteinuria: an enzymatic disease of the podocyte?

Authors:  Peter Mundel; Jochen Reiser
Journal:  Kidney Int       Date:  2009-11-18       Impact factor: 10.612

8.  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

Authors:  Christian Faul; Mary Donnelly; Sandra Merscher-Gomez; Yoon Hee Chang; Stefan Franz; Jacqueline Delfgaauw; Jer-Ming Chang; Hoon Young Choi; Kirk N Campbell; Kwanghee Kim; Jochen Reiser; Peter Mundel
Journal:  Nat Med       Date:  2008-09       Impact factor: 53.440

9.  Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.

Authors:  Cheryl Carson; Pichai Raman; Jennifer Tullai; Lei Xu; Martin Henault; Emily Thomas; Sarita Yeola; Jianmin Lao; Mark McPate; J Martin Verkuyl; George Marsh; Jason Sarber; Adam Amaral; Scott Bailey; Danuta Lubicka; Helen Pham; Nicolette Miranda; Jian Ding; Hai-Ming Tang; Haisong Ju; Pamela Tranter; Nan Ji; Philipp Krastel; Rishi K Jain; Andrew M Schumacher; Joseph J Loureiro; Elizabeth George; Giuliano Berellini; Nathan T Ross; Simon M Bushell; Gül Erdemli; Jonathan M Solomon
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

10.  The Role of Angiotensin II in Glomerular Volume Dynamics and Podocyte Calcium Handling.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Vladislav Levchenko; Bradley T Endres; Alexander Staruschenko
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

View more
  19 in total

1.  A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.

Authors:  Daria V Ilatovskaya; Gregory Blass; Oleg Palygin; Vladislav Levchenko; Tengis S Pavlov; Michael N Grzybowski; Kristen Winsor; Leonid S Shuyskiy; Aron M Geurts; Allen W Cowley; Lutz Birnbaumer; Alexander Staruschenko
Journal:  J Am Soc Nephrol       Date:  2018-05-23       Impact factor: 10.121

2.  Stop TRPC5 in Kidney Disease: A Game Changer for Renal Allograft Protection?

Authors:  Xuexiang Wang; Jochen Reiser
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

Review 3.  Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.

Authors:  Juan Lorenzo Pablo; Anna Greka
Journal:  Trends Pharmacol Sci       Date:  2019-11-05       Impact factor: 14.819

Review 4.  TRPC channels: Structure, function, regulation and recent advances in small molecular probes.

Authors:  Hongbo Wang; Xiaoding Cheng; Jinbin Tian; Yuling Xiao; Tian Tian; Fuchun Xu; Xuechuan Hong; Michael X Zhu
Journal:  Pharmacol Ther       Date:  2020-01-28       Impact factor: 12.310

5.  Renal physiology: TRPC5 inhibition to treat progressive kidney disease.

Authors:  Jenny van der Wijst; René J M Bindels
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

6.  Protective role of Trpc6 knockout in the progression of diabetic kidney disease.

Authors:  Denisha Spires; Daria V Ilatovskaya; Vladislav Levchenko; Paula E North; Aron M Geurts; Oleg Palygin; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-20

Review 7.  Histone modification in podocyte injury of diabetic nephropathy.

Authors:  Simeng Wang; Xinyu Zhang; Qinglian Wang; Rong Wang
Journal:  J Mol Med (Berl)       Date:  2022-08-30       Impact factor: 5.606

8.  Autonomous Calcium Signaling in Human and Zebrafish Podocytes Controls Kidney Filtration Barrier Morphogenesis.

Authors:  Lydia Djenoune; Ritu Tomar; Aude Dorison; Irene Ghobrial; Heiko Schenk; Jan Hegermann; Lynne Beverly-Staggs; Alejandro Hidalgo-Gonzalez; Melissa H Little; Iain A Drummond
Journal:  J Am Soc Nephrol       Date:  2021-04-28       Impact factor: 14.978

Review 9.  The glomerular filtration barrier: a structural target for novel kidney therapies.

Authors:  Ilse S Daehn; Jeremy S Duffield
Journal:  Nat Rev Drug Discov       Date:  2021-07-14       Impact factor: 84.694

10.  Clemizole and La3+ salts ameliorate angiotensin II-induced glomerular hyperpermeability in vivo.

Authors:  Julia Dolinina; Anna Rippe; Carl M Öberg
Journal:  Physiol Rep       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.